Research
Hormonal
Bariatric surgery significantly reduces the incidence of mortality and cardiovascular diseases compared to best non-surgical care in patients with obesity.
Bariatric surgery offers a dramatic reduction in mortality and cardiovascular disease risk compared to non-surgical weight loss methods. For patients with obesity, surgery is the most effective intervention for long-term survival and cardiovascular health.
StrongSupportsVERY_HIGH confidence
Bariatric surgery reduces the incidence of mortality and cardiovascular diseases dramatically compared to best non-surgical care in patients with obesity.
Why this rating
Based on a systematic review and meta-analysis (Chapter 9), which provides the highest level of evidence for comparative effectiveness.
Source
Perioperative management of pulmonary and cardiovascular comorbidities in patients undergoing bariatric surgery
Sophie Laura van Veldhuisen · 2022
DOI 10.18174/579240
cohort · n=5682
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →